These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 31478151)
1. Sensorimotor Perceptive Rehabilitation Integrated (SPRInt) program: exercises with augmented movement feedback associated to botulinum neurotoxin in idiopathic cervical dystonia-an observational study. Castagna A; Caronni A; Crippa A; Sciumè L; Giacobbi G; Corrini C; Montesano A; Ramella M Neurol Sci; 2020 Jan; 41(1):131-138. PubMed ID: 31478151 [TBL] [Abstract][Full Text] [Related]
2. A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia. Hu W; Rundle-Gonzalez V; Kulkarni SJ; Martinez-Ramirez D; Almeida L; Okun MS; Wagle Shukla A Parkinsonism Relat Disord; 2019 Jun; 63():195-198. PubMed ID: 30837195 [TBL] [Abstract][Full Text] [Related]
3. Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance. Samotus O; Lee J; Jog M J Neurol; 2018 Jun; 265(6):1269-1278. PubMed ID: 29557988 [TBL] [Abstract][Full Text] [Related]
4. An analysis of the efficacy of botulinum neurotoxin type a in treating cervical dystonia. Zhou X; Li ZF; Guo XZ; Wei Q; Niu YN; Li M; Xia JN; Chen LP Technol Health Care; 2024; 32(4):2421-2430. PubMed ID: 38073352 [TBL] [Abstract][Full Text] [Related]
5. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia. Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697 [TBL] [Abstract][Full Text] [Related]
6. Study protocol: multimodal physiotherapy as an add-on treatment to botulinum neurotoxin type A therapy for patients with cervical dystonia: DysPT-multi-a prospective, multicentre, single-blind, randomized, controlled study. Werner C; Loudovici-Krug D; Derlien S; Rakers F; Smolenski UC; Lehmann T; Best N; Günther A Trials; 2021 Oct; 22(1):740. PubMed ID: 34696821 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Brin MF; Lew MF; Adler CH; Comella CL; Factor SA; Jankovic J; O'Brien C; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M Neurology; 1999 Oct; 53(7):1431-8. PubMed ID: 10534247 [TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type B for cervical dystonia. Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941 [TBL] [Abstract][Full Text] [Related]
9. Assessment of Botulinum Neurotoxin Injection for Dystonic Hand Tremor: A Randomized Clinical Trial. Rajan R; Srivastava AK; Anandapadmanabhan R; Saini A; Upadhyay A; Gupta A; Vishnu VY; Pandit AK; Vibha D; Singh MB; Bhatia R; Goyal V; Dwivedi SN; Srivastava P; Prasad K JAMA Neurol; 2021 Mar; 78(3):302-311. PubMed ID: 33346814 [TBL] [Abstract][Full Text] [Related]
10. The effect of a single botulinum toxin treatment on somatosensory processing in idiopathic isolated cervical dystonia: an observational study. De Pauw J; Cras P; Truijen S; Mercelis R; Michiels S; Saeys W; Vereeck L; Hallemans A; De Hertogh W J Neurol; 2018 Nov; 265(11):2672-2683. PubMed ID: 30196326 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial. Pappert EJ; Germanson T; Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274 [TBL] [Abstract][Full Text] [Related]
12. Botulinum Toxin Type A Injection for Cervical Dystonia in Adults with Dyskinetic Cerebral Palsy. Yi YG; Kim K; Yi Y; Choi YA; Leigh JH; Bang MS Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772695 [TBL] [Abstract][Full Text] [Related]
13. The effect of botulinum toxin on anxiety in cervical dystonia: A prospective, observational study. Sugar D; Patel R; Comella C; González DA; Gray G; Stebbins GT; Mahajan A Parkinsonism Relat Disord; 2023 Sep; 114():105792. PubMed ID: 37540934 [TBL] [Abstract][Full Text] [Related]
14. KinesioTaping after botulinum toxin type A for cervical dystonia in adult patients. Dec-Ćwiek M; Porębska K; Sawczyńska K; Kubala M; Witkowska M; Zmijewska K; Antczak J; Pera J Brain Behav; 2022 Apr; 12(4):e2541. PubMed ID: 35238494 [TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Brashear A; Lew MF; Dykstra DD; Comella CL; Factor SA; Rodnitzky RL; Trosch R; Singer C; Brin MF; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M Neurology; 1999 Oct; 53(7):1439-46. PubMed ID: 10534248 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of single-photon emission computed tomography aided botulinum toxin injection in cervical dystonia: A double-blind, randomized study. Teng F; Malam Djibo I; Chen S; Su J; Pan Y; Zhang X; Xu Y; Feng L; Pan L; Jin L Parkinsonism Relat Disord; 2021 Oct; 91():77-82. PubMed ID: 34537494 [TBL] [Abstract][Full Text] [Related]
18. Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study. Mordin M; Masaquel C; Abbott C; Copley-Merriman C BMJ Open; 2014 Oct; 4(10):e005150. PubMed ID: 25324317 [TBL] [Abstract][Full Text] [Related]
19. Long-Term Specialized Physical Therapy in Cervical Dystonia: Outcomes of a Randomized Controlled Trial. van den Dool J; Visser B; Koelman JH; Engelbert RH; Tijssen MA Arch Phys Med Rehabil; 2019 Aug; 100(8):1417-1425. PubMed ID: 30796919 [TBL] [Abstract][Full Text] [Related]
20. Pallidal neurostimulation versus botulinum toxin injections in the treatment of cervical dystonia: protocol of a randomized, sham-controlled trial (StimTox-CD). Odorfer TM; Malzahn U; Matthies C; Heuschmann PU; Volkmann J Neurol Res Pract; 2019; 1():2. PubMed ID: 33324868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]